FDA PMA FDA Class 2 Approved 🇺🇸 United States

Catheters, Transluminal Coronary Angioplasty, Percutaneous

PMA: P910031 · Supplement: S022 · Decision Feb 16, 2006
Classifications
1
FEI Numbers
70
Registration Numbers
70

Basic Information

Device Name
Catheters, Transluminal Coronary Angioplasty, Percutaneous
Trade Name
MERLIN PTCA CATHETER (OTW) AND NC MERLIN PTCA CATHETER (OTW)
PMA Number
P910031
Supplement Number
S022
Device Class
FDA Class 2
Product Code
LOX
Generic Name
Catheters, transluminal coronary angioplasty, percutaneous
Regulation Number
870.5100
Medical Specialty
Cardiovascular
Advisory Committee
Cardiovascular
Decision
Approved
Decision Code
APPR
Decision Date
February 16, 2006
Date Received
November 1, 2004
Supplement Type
Normal 180 Day Track
Supplement Reason
Change Design/Components/Specifications/Material
Expedited Review
N

Advisory Committee Statement

APPROVAL FOR THE MERLIN PTCA CATHETER (OTW) AND NC MERLIN PTCA CATHETER (OTW). THE MERLIN PTCA CATHETER (OTW) IS INDICATED FOR USE IN BALLOON DILATATION OF THE STENOTIC PORTION OF A CORONARY ARTERY OR BYPASS GRAFT STENOSIS FOR THE PURPOSE OF IMPROVING MYOCARDIAL PERFUSION. THE NC MERLIN PTCA CATHETER (OTW) IS INDICATED FOR USE IN BALLOON DILATATION OF THE STENOTIC PORTION OF A CORONARY ARTERY OR BYPASS GRAFT STENOSIS FOR THE PURPOSE OF IMPROVING MYOCARDIAL PERFUSION, AND FOR THE POST-DELIVERY EXPANSION OF BALLOON EXPANDABLE STENTS.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
LOX Catheters, Transluminal Coronary Angioplasty, Percutaneous